Related Experiment Video
Updated: Mar 13, 2026

Recurrent Escherichia coli Urinary Tract Infection Triggered by Gardnerella vaginalis Bladder Exposure in Mice
Published on: December 4, 2020
Antibiotic Resistance in Pediatric Urinary Tract Infections
Jeremy S Stultz1, Christopher D Doern2, Emily Godbout3
1Department of Pharmacotherapy and Outcomes Science, Virginia Commonwealth University School of Pharmacy, Smith Building, Room 435, 410 N 12th Street, P.O. Box 980533, Richmond, VA, 23298, USA. jsstultz@vcu.edu.
Insights
Antibiotic resistance in pediatric urinary tract infections (UTIs) is rising, particularly with prior antibiotic exposure. Judicious prescribing is crucial to combat resistant organisms and improve treatment outcomes.
Area of Science:
- Pediatric infectious diseases
- Antimicrobial resistance
- Urology
Background:
- Urinary tract infections (UTIs) are a significant concern in pediatric populations.
- Increasing antibiotic resistance rates pose a challenge to effective UTI treatment.
- Prior antibiotic exposure is a key risk factor for resistant UTI pathogens.
Approach:
- Reviewing current trends in pediatric UTI antibiotic resistance.
- Identifying risk factors associated with resistant organism acquisition.
- Highlighting the need for judicious antibiotic prescribing in children.
- Examining the challenges in treating complex pediatric UTIs.
Key Points:
- Pediatric UTIs demonstrate increasing resistance to common antibiotics.
- Previous antibiotic use elevates the risk of acquiring resistant bacteria.
- Children with complex medical histories are susceptible to multidrug-resistant organisms like ESBL-producers.
- There is a lack of data on how antibiotic susceptibility testing impacts UTI treatment success.
Conclusions:
- Urgent need for antibiotic stewardship in pediatric care to mitigate resistance.
- Further research is required to understand the clinical impact of antibiotic susceptibility testing in pediatric UTIs.
- Addressing antibiotic resistance in pediatric UTIs is critical for public health.
Abstract:
Urinary tract infections (UTIs) are a common problem in pediatric patients. Resistance to common antibiotic agents appears to be increasing over time, although resistance rates may vary based on geographic region or country. Prior antibiotic exposure is a pertinent risk factor for acquiring resistant organisms during a first UTI and recurrent UTI. Judicious prescribing of antibiotics for common pediatric conditions is needed to prevent additional resistance from occurring. Complex pediatric patients with histories of hospitalizations, prior antibiotic exposure, and recurrent UTIs are also at high risk for acquiring UTIs due to extended spectrum beta-lactamase-producing organisms. Data regarding the impact of in vitro antibiotic susceptibility testing interpretation on UTI treatment outcomes is lacking.
Related Concept Videos
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Urine Studies II: Urine Culture and Sensitivity Test
Development of Antibiotic Resistance
Pharmacokinetics in Pediatric Patients: Drug Excretion
Antibiotic Selection
Urinary Tract Infection II: Pathophysiology

